Korean J Psychopharmacol.
2003 Sep;14(3):244-251.
Association between A-1438G Polymorphisms of 5-HT2A Receptor Promoter Gene and Tardive Dyskinesia
- Affiliations
-
- 1Department of Psychiatry, College of Medicine, Soonchunhyang University Hospital, Seoul, Korea.
- 2Department of Laboratory, College of Medicine, Soonchunhyang University Hospital, Seoul, Korea.
- 3Department of Psychiatry, College of Medicine, Soonchunhyang University Hospital, Chunan, Korea.
Abstract
OBJECTIVE
Tardive dyskinesia (TD) is one of the serious side effects caused by long-term treatment with neuroleptic medication. Many investigators are trying to elucidate the pathophysiological mechanism of TD, and some candidate genetic polymorphisms have been reported as associated with TD. This study investigated the association of the 5-HT2A receptor promoter gene polymorphisms with TD in Korean schizophrenic subjects. METHODS: The subjects in this study of 5-HT2A receptor gene polymorphisms were 119 schizophrenia patients, 59 with TD and 60 without. TD was evaluated by using the Abnormal Involuntary Movement Scale (AIMS). Genomic DNA was amplified by PCR and digested with MspI. RESULTS: There were no statistically significant differences in the demographic variables of age, sex ratio, duration of illness and duration of antipsychotic drug exposure between the TD and control groups. 1) A-1438G polymorphisms and TD, By comparing the TD and control groups, the -1438A/G allele was found to be associated with a significantly increased risk for TD (x2=5.560, df=1, p=0.018). 2) Three AIMS categories of TD and A-1438G genotype. There were statistically significant differences in the three AIMS categories (x2=6.835, df=2, p=0.033). CONCLUSION: These results suggest that the -1438A/G genotype of the 5-HT2A receptor gene is related to the development of TD. The -1438A/G genotypes were associated with significantly higher AIMS orofacial dyskinesia scores. These findings suggest that the 5-HT2A receptor gene is partly associated with susceptibility to TD in patients with chronic schizophrenia.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Tardive Dyskinesia: Treatment with Aripiprazole
- Association between Tardive Dyskinesia and T103C Polymorphisms of 5-HT2A Receptor Gene
- Association between 5-HT2A Receptor Gene Promoter -1438A/G Polymorphism and Bipolar Disorder in a Korean Population
- Association of Tardive Dyskinesia with Cognitive Deficit in Schizophrenia
- Low Dose Olanzapine Induced Tardive Dyskinesia: A Case Report
